Back | Next |
home / stock / avxl / avxl message board
Subject | By | Source | When |
---|---|---|---|
Wondering if Missling will put Rett aside for | Jonjones325 | investorshub | 07/23/2024 9:19:47 PM |
One ferry ride. | LakeshoreLeo1953 | investorshub | 07/23/2024 9:12:51 PM |
Coming presentations by Anavex | nidan7500 | investorshub | 07/23/2024 9:06:56 PM |
Extremely bullish per Stocktwits | georgejjl | investorshub | 07/23/2024 8:32:47 PM |
Speaking of $10, any concrete positive news, possibly | xodcode | investorshub | 07/23/2024 8:30:31 PM |
We closed at $6.58. Volume at | k9uwa | investorshub | 07/23/2024 8:23:49 PM |
the best have yet to come.JUST HOLD ON | longtermbeliever | investorshub | 07/23/2024 8:12:53 PM |
$AVXL close: 6.58 +0.67 (+11.34%) | RedShoulder | investorshub | 07/23/2024 8:10:10 PM |
Im not getting exciting until we close above | tredenwater2 | investorshub | 07/23/2024 7:44:50 PM |
Part A of the phase 2 Anavex 3-71 | georgejjl | investorshub | 07/23/2024 7:42:45 PM |
Coming presentations by Anavex | georgejjl | investorshub | 07/23/2024 7:36:37 PM |
We'll be lucky if the EMA sees the | tradeherpete | investorshub | 07/23/2024 7:30:31 PM |
Trading seems to be counter intuitive, when it's | tradeherpete | investorshub | 07/23/2024 7:24:08 PM |
I think you are incorrect on the way | Steady_T | investorshub | 07/23/2024 7:20:02 PM |
Well done, sir. I hope you recoup all | abew4me | investorshub | 07/23/2024 7:08:01 PM |
Here we go back up, now 6.59 +0.68 | RedShoulder | investorshub | 07/23/2024 6:59:52 PM |
It appears that $AVXL stock price should close | georgejjl | investorshub | 07/23/2024 6:56:34 PM |
I won't be surprised if this closes flat | xodcode | investorshub | 07/23/2024 6:51:41 PM |
I won't be surprised if this closes flat | kund | investorshub | 07/23/2024 6:41:37 PM |
More trading activity and a strong rise in | Mr.Fields | investorshub | 07/23/2024 6:04:30 PM |
News, Short Squeeze, Breakout and More Instantly...
Anavex Life Sciences Corp. Company Name:
AVXL Stock Symbol:
NASDAQ Market:
Anavex Life Sciences Corp. Website:
Oral, once daily blarcamesine significantly slowed clinical decline for early Alzheimer's disease patients with good comparative safety profile and no associated neuroimaging adverse events Clinical benefit of blarcamesine consistently observed for both 30 mg and 50 mg treatment groups ...
2024-07-18 02:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative, neurodevelopmental and neuropsyc...